RCB

EQS-News: Pyrum Innovations AG publishes financial figures for Q4 and preliminary results for the financial year 2023

Retrieved on: 
Wednesday, April 10, 2024

Sales increased by 17% year-on-year to EUR 1,147 thousand (2022: EUR 982 thousand).

Key Points: 
  • Sales increased by 17% year-on-year to EUR 1,147 thousand (2022: EUR 982 thousand).
  • As a result, total output decreased by 32% year-on-year to EUR 12,934 thousand (2022: EUR 19,069 thousand).
  • The Trading Update Q4 2023 of Pyrum Innovations AG is available on the company's website at https://www.pyrum.net/en/investors/financial-publications/ .
  • The publication of the final figures and the Annual Report 2023 is scheduled for 16 May 2024.

Recovered Carbon Black Market Projected to Reach $3,978.80 million by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Friday, April 5, 2024

Recovered carbon black (rCB) is setting a new standard in sustainable material innovation as a green alternative emerging from recycling end-of-life tires and rubber products.

Key Points: 
  • Recovered carbon black (rCB) is setting a new standard in sustainable material innovation as a green alternative emerging from recycling end-of-life tires and rubber products.
  • The key players in the Recovered Carbon Black Market include Imerys S.A., Birla Carbon U.S.A., Inc., Orion Engineered Carbons S.A., Hi-Green Carbon Ltd. by Radhe Group of Energy, Black Bear Carbon B.V., and others.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Recovered Carbon Black Market.
  • "Dive into the Recovered Carbon Black Market Landscape: Explore 182 Pages of Insights, 468 Tables, and 26 Figures"

Recovered Carbon Black Market Projected to Reach $3,978.80 million by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Friday, April 5, 2024

Recovered carbon black (rCB) is setting a new standard in sustainable material innovation as a green alternative emerging from recycling end-of-life tires and rubber products.

Key Points: 
  • Recovered carbon black (rCB) is setting a new standard in sustainable material innovation as a green alternative emerging from recycling end-of-life tires and rubber products.
  • The key players in the Recovered Carbon Black Market include Imerys S.A., Birla Carbon U.S.A., Inc., Orion Engineered Carbons S.A., Hi-Green Carbon Ltd. by Radhe Group of Energy, Black Bear Carbon B.V., and others.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Recovered Carbon Black Market.
  • "Dive into the Recovered Carbon Black Market Landscape: Explore 182 Pages of Insights, 468 Tables, and 26 Figures"

Study Finds Opto-Acoustic Imaging During Neoadjuvant Therapy Correlates to Pathologic Response

Retrieved on: 
Friday, December 8, 2023

Similarly, an increase in OA/US scan scores after cycle 1 may be an important indicator of poor response to chemotherapy, allowing for intervention earlier in the course of therapy.

Key Points: 
  • Similarly, an increase in OA/US scan scores after cycle 1 may be an important indicator of poor response to chemotherapy, allowing for intervention earlier in the course of therapy.
  • The poster Changes in Breast Cancer Opto-Acoustic Imaging Features During Neoadjuvant Therapy and Correlation with Pathologic Response: A Feasibility Study was presented on Friday, December 8, by Basak Dogan, MD, director of breast imaging research at the University of Texas Southwestern Medical Center, Department of Radiology, Harold C. Simmons Comprehensive Cancer Center.
  • The analysis highlights the role OA/US can play in predicting response to neoadjuvant therapy (NAC) by evaluating the OA/US imaging feature changes.
  • Seno Medical Instruments, Inc. is a San Antonio, Texas-based medical imaging company committed to developing and commercializing a new modality in cancer diagnosis: opto-acoustic imaging.

EQS-News: Pyrum Innovations AG publishes financial figures for the first nine months of 2023

Retrieved on: 
Thursday, December 14, 2023

Sales in the first nine months totalled EUR 842 thousand, around 18% higher than in the same period of the previous year (9M 2022: EUR 714 thousand).

Key Points: 
  • Sales in the first nine months totalled EUR 842 thousand, around 18% higher than in the same period of the previous year (9M 2022: EUR 714 thousand).
  • Own work capitalised amounted to EUR 9,828 thousand (9M 2022: EUR 13,171 thousand) as construction of the plant expansion in Dillingen progressed according to plan.
  • Cash and cash equivalents as of 30 September 2023 amounted to EUR 4,410 thousand (31 December 2022: EUR 12,519 thousand).
  • For the full year 2023, the management is currently expecting sales of between EUR 1.1 million and EUR 1.5 million.

Bridgestone and Michelin to Present Findings from Year-Long Effort on Recovered Carbon Black in Joint White Paper

Retrieved on: 
Monday, November 6, 2023

Bridgestone and Michelin publish white paper to share the results of their work on the increased use of recovered carbon black in the tire industry.

Key Points: 
  • Bridgestone and Michelin publish white paper to share the results of their work on the increased use of recovered carbon black in the tire industry.
  • The white paper follows a position paper, released earlier this year, on the companies' joint initiative to increase the use of recovered carbon black
    TOKYO and CLERMONT-FERRAND, France, Nov. 6, 2023 /PRNewswire/ -- Following the joint call to action around recovered carbon black at the 2021 Smithers rCB conference, Bridgestone Corporation and Michelin Group have published a joint technical white paper to share the results of their work with stakeholders in the rCB community to develop a proposed global standard to increase the utilization of recovered carbon black material in tires.
  • The joint white paper titled, Bridgestone & Michelin: Recovered Carbon Black Guidelines, can be found on rcbrubber.com.
  • In 2022, the two companies released a position paper focused on the joint initiative to increase the use of recovered carbon black.

The Boca Bearings Company Has Expanded Their Line of One-Way Bearings

Retrieved on: 
Friday, September 29, 2023

BOYNTON BEACH, Fla., Sept. 29, 2023 /PRNewswire-PRWeb/ -- Boca Bearings is pleased to announce the release of its new and expanded One-Way Bearing Series. One-way clutch or Sprag style bearings are constructed from a drawn cup with needle roller clutches and have a small radial section height. They are often called one-way bearings, anti-reverse bearings, and clutch bearings.

Key Points: 
  • They are often called one-way bearings, anti-reverse bearings, and clutch bearings.
  • BOYNTON BEACH, Fla., Sept. 29, 2023 /PRNewswire-PRWeb/ -- Boca Bearings is pleased to announce the release of its new and expanded One-Way Bearing Series.
  • They are often called one-way bearings, anti-reverse bearings, and clutch bearings.
  • The one-way clutch bearings (OWC), also known as Origin One Way bearings are extra narrow and high-performance bearings available as small as a 5.4mm width.

Nauticus Robotics Announces Term Loan Financing of up to $20 Million

Retrieved on: 
Thursday, September 21, 2023

The Term Loan Agreement provides Nauticus with up to $20 million in secured term loans (the "Loans"), of which $11.6 million has already been funded.

Key Points: 
  • The Term Loan Agreement provides Nauticus with up to $20 million in secured term loans (the "Loans"), of which $11.6 million has already been funded.
  • The Company is actively discussing a larger round of capital with new investors, beyond the available capacity of the Term Loan Agreement, to support its service offering expansion.
  • Their continued investment underscores confidence in the company's strategic direction and growth potential," said Nicolaus Radford, CEO of Nauticus.
  • We are excited about the opportunities this financing provides as we continue to build out our fleet of robots."

EQS-News: Pyrum Innovations AG publishes figures for the first half of 2023

Retrieved on: 
Saturday, September 16, 2023

Sales in the first six months amounted to EUR 501 thousand and were thus slightly higher than in the first half of 2022 (EUR 485 thousand).

Key Points: 
  • Sales in the first six months amounted to EUR 501 thousand and were thus slightly higher than in the first half of 2022 (EUR 485 thousand).
  • Own work capitalised amounted to EUR 7,613 thousand (H1 2022: EUR 8,495 thousand) as construction of the plant expansion in Dillingen progressed according to plan.
  • Cash and cash equivalents as of 30 June 2023 amounted to EUR 5,431 thousand (December 31, 2022: EUR 12,519 thousand).
  • Pyrum Innovations AG will offer an English-language webcast for investors, private shareholders and members of the press on the current business development on Monday, 18 September 2023, at 10:00 am (CEST).

KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and Manufacturing

Retrieved on: 
Tuesday, September 12, 2023

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the launch of SUREmAb ™, an offering built on the robustness of KBI’s SUREtechnology Platform™, that allows for optimized, safe, and cost-efficient monoclonal antibody (mAb) development and manufacturing.

Key Points: 
  • KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the launch of SUREmAb ™, an offering built on the robustness of KBI’s SUREtechnology Platform™, that allows for optimized, safe, and cost-efficient monoclonal antibody (mAb) development and manufacturing.
  • In addition, SUREmAb is engineered to achieve titers of up to 10 g/L with a lower-cost workflow to optimize operational efficiency and maximize ROI.
  • "SUREmAb represents not just the culmination of decades of biologics production expertise but our vision for the future of mAb development,” said KBI Chief Scientific Officer, Sigma Mostafa.
  • The operational consolidation of KBI Biopharma and Selexis, announced during BIO International 2023, played an important role in the operations that power the SUREmAb technology, enabling KBI to streamline processes and offer greater efficiencies in monoclonal antibody development and manufacturing.